Discover one of our 28 local entrepreneurial communities »
Be the first to know as we launch in new countries and markets around the globe.
Interested in bringing MIT Technology Review to your local market?
Unsupported browser: Your browser does not meet modern web standards. See how it scores »
Researchers at the Venter Institute explain their groundbreaking techniques.
With H1N1 vaccine supplies delayed, attention turns to faster-to-make “virus-like particles.”
Scientists look to tobacco plants for a norovirus vaccine.
Scientists are exploring faster approaches to making vaccines against the H1N1 virus.
A diverse group of antibodies may work together to neutralize the virus, suggesting a new approach to vaccination.
A new approach primes antibodies to instantly attack cancers, HIV, and other diseases.
A novel type of vaccine could be rapidly designed for a specific flu strain and then quickly manufactured.